Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Oxford COVID vaccine data could go before regulators this year-director

Tue, 25th Aug 2020 07:57

LONDON, Aug 25 (Reuters) - An experimental COVID-19 vaccine
being developed by the University of Oxford and AstraZeneca
could be put before regulators this year if scientists
are able to gather enough data, the director of the Oxford
Vaccine Group said on Tuesday.

"It is just possible that if the cases accrue rapidly in the
clinical trials, that we could have that data before regulators
this year, and then there would be a process that they go
through in order to make a full assessment of the data," Andrew
Pollard told BBC Radio.

(Reporting by Kate Holton and Sarah Young; editing by Alistair
Smout)

Related Shares

More News

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

Today 09:49

All under-40s to be offered alternative to AstraZeneca vaccine

All under-40s to be offered alternative to AstraZeneca vaccine

Today 08:49

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

Today 08:32

AstraZeneca's Imfinzi demonstrates benefit in combination with antibody

(Sharecast News) - AstraZeneca reported on Friday that 'Imfinzi' and tremelimumab with chemotherapy demonstrated an overall survival benefit in the 'POSEIDON' trial for first-line stage four non-small cell lung cancer, making it the first phase 3 trial to demonstrate an overall survival benefit with tremelimumab.

Today 07:42

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.